Skip to main content
Clinical Trials/NCT07261839
NCT07261839Enrolling By InvitationNot Applicable

Effect of Visualized Meditation on Anxiety, Pain, and Comfort in Patients Undergoing Endoscopy

University of Gaziantep1 site in 1 country72 target enrollmentStarted: July 14, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Enrolling By Invitation
Enrollment
72
Locations
1
Primary Endpoint
VAS Pain and Comfort Scale

Study Overview

Brief Summary

Endoscopy is one of the most frequently performed procedures for the early diagnosis and treatment of many diseases and plays a crucial role in the diagnosis and treatment of upper gastrointestinal disorders. Sometimes, endoscopy may be the only option for detecting certain diseases of the stomach and larynx. However, for many patients, endoscopy is considered an invasive, highly painful, and extremely uncomfortable procedure. Furthermore, anxiety and fear felt before the procedure can cause physical and emotional discomfort, disrupt patient comfort, and cause pain.

Detailed Description

Endoscopy is one of the most frequently performed procedures for the early diagnosis and treatment of various gastrointestinal disorders and plays a critical role, particularly in the evaluation of upper gastrointestinal system pathologies. In certain clinical situations, endoscopy may be the only reliable method for identifying diseases occurring in the stomach, esophagus, and larynx. Despite its diagnostic and therapeutic value, endoscopy is commonly perceived by patients as an invasive, uncomfortable, and often painful procedure. In addition, the anxiety and fear experienced before the procedure can lead to both physical and emotional distress, negatively affecting overall patient comfort and potentially intensifying the perception of pain.

Moderate to severe anxiety during endoscopy has been shown to increase the likelihood of procedural difficulties, prolong the duration of the examination, reduce patient satisfaction, and elevate the risk of complications. These adverse effects highlight the importance of implementing non-pharmacological strategies aimed at reducing anxiety and improving patient comfort. One such approach-guided visualization or visualized meditation-has gained attention as a simple, cost-effective, and patient-friendly method that promotes relaxation, reduces emotional tension, and supports pain management.

Considering the potential of guided visualization to enhance tolerance to the procedure and improve patient experiences, researchers were motivated to explore its effectiveness in this specific population. Therefore, this study was designed to determine the effect of visualized meditation applied to patients undergoing endoscopy on their levels of anxiety, pain, and comfort.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients over the age of 18, with no hearing impairment,
  • •Students undergoing endoscopy for the first time,
  • •Not diagnosed with a psychiatric disorder and therefore not on medication,
  • •Willing to participate in the study

Exclusion Criteria

  • •Patients who refused to participate in the study, underwent endoscopy for biopsy, or received deep sedation.
  • •Patients who volunteered to participate and then wished to withdraw from the study at any stage.

Arms & Interventions

Visualized meditation group

Active Comparator

Visualized meditation for patients who have had an endoscopy

Intervention: Visualized meditation (Other)

Control group

No Intervention

Control group

Outcomes

Primary Outcomes

VAS Pain and Comfort Scale

Time Frame: From enrollment to the end of treatment at 4 months

This scale was developed by Price and colleagues (1983). It is used to measure subjective pain and comfort levels. The scale is represented by a 10-cm line representing the lowest and highest pain scores (0: no pain/discomfort, 10: most intolerable pain/discomfort).

The State Trait Anxiety Inventory (STAI)

Time Frame: "From enrollment to the end of treatment at 4 months

The State Trait Anxiety Inventory (STAI), developed by Spielberger et al. in 1964, will be used to measure anxiety in this study. The scale has two dimensions: the STAI-S, which measures state anxiety, and the STAI-T, which measures trait anxiety. The STAI-S and STAI-T each consist of 20 items. Items 1-40 on the scale measure anxiety in four ways. The lowest score for both dimensions of the scale is 20, and the highest score is 80. As the score increases, the level of anxiety also increases.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Tuğba Albayram

Research Assistant Dr

University of Gaziantep

Study Sites (1)

Loading locations...

Similar Trials